ODC1 and esophageal squamous cell carcinoma: Based on the important role of ODC in ESCC progression, ESCC cells were treated with DFMO, a potent substrate analog and specific irreversible inhibitor of ODC.23 The data showed that treatment with DFMO dose-dependently decreased ODC activity in ESCC cells (Fig. 5a).